Thursday, May 5, 2011

Read Kamehasutra Doujinshi

New diabetes treatment

  • New diabetes treatment
    The Food and Drug Administration approved a new drug to fight type 2 diabetes. Although it is the leading cause of death in Mexico, its entry into the domestic market has no date .
  • Cofepris Linagliptin being revised, a drug to fight type 2 diabetes. (Photo: photos to go) RELATED ITEMS
    Diabetes and pressure, university evils Due to lack of exercise, young people suffer wrongs that were once typical of the elderly.


    The psychology of the products 'miracle' Mexicans are overweight and hypertension were already 17 million and seek immediate solutions.
A sweet to save Mexico's health National Polytechnic Institute Students created a gummy with folic acid and saccharin.
Does alcohol prevent diabetes?

Drink alcohol in moderation reduces 40% the risk of developing type 2 diabetes, a study says.
By:
Ivet Rodríguez
MEXICO CITY (Manufacturing Magazine) - Yesterday, the
FDA (Food and Drug Administration)
approved the first of four drugs that the pharmaceutical Boehringer Ingelheim and Eli Lilly developed for the treatment of type 2 diabetes, the leading cause of death in Mexico and third in the U.S..
This is the
Linagliptin The
president and CEO of Boehringer Ingelheim, Miguel Salazar

, acknowledged that there is still no date for the launch of this new drug in the Mexican market. It is currently under review by the Federal Commission for Protection Against Health Risks (Cofepris). is expected that as part of the alliance that both pharmaceutical made in January, to develop four compounds: the BI10773 Linagliptin and Boehringer Ingelheim, and basal insulin analogs LY2605541 and LY2963016, Eli Lilly.También the possibility of developing and jointly market the monoclonal antibody anti-TGF-beta Lilly.

"Through this partnership, both companies seek to research, develop and market products for the treatment of type 2 diabetes," he said at a press conference the director of Boehringer Ingelheim. More Manufacturing news magazine

SEE, THINK, WRITE La Cofepris está revisando la Linagliptina, medicamento para combatir la diabetes tipo 2. (Foto: photos to go)
. Greetings
Diploma in Management in Public Administration UN can read us
FACEBOOK

http://www.facebook.com/ # / profile.php? id = 1020328166

www.consultajuridica.blogspot.com
www.el-observatory politico.blogspot.com

www.lobbyingchile.blogspot.com

www.calentamientoglobalchile . blogspot.com

www.respsoem2.blogspot.com

www.coachingdechile.blogspot.com


www.chile-renovables.blogspot.com

CEL: 93934521 Santiago-Chile

Apply our training courses and consulting
in PUBLIC ADMINISTRATION MANAGEMENT-LEADERSHIP - KNOWLEDGE MANAGEMENT - CORPORATE SOCIAL RESPONSIBILITY - LOBBY - BUSINESS COACHING-RENEWABLE, consulting nationally and internationally and are available for OTEC Y OTIC in Chile

RESPMEDIC

0 comments:

Post a Comment